Published in Leukemia on March 01, 2006
Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids. Bioorg Med Chem (2007) 1.20
Novel analogs of D-e-MAPP and B13. Part 1: synthesis and evaluation as potential anticancer agents. Bioorg Med Chem (2007) 1.08
A review of ceramide analogs as potential anticancer agents. Future Med Chem (2013) 0.92
Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death. Biochim Biophys Acta (2013) 0.91
Cytotoxic activity and quantitative structure activity relationships of arylpropyl sulfonamides. Korean J Physiol Pharmacol (2013) 0.81
Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines. J Nat Prod (2012) 0.80
Bioactive secondary metabolites from acid mine waste extremophiles. Nat Prod Commun (2014) 0.78
The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. J Ethnopharmacol (2016) 0.75
Cytotoxicities and Quantitative Structure Activity Relationships of B13 Sulfonamides in HT-29 and A549 Cells. Korean J Physiol Pharmacol (2011) 0.75
Ceramide as a Target of Marine Triterpene Glycosides for Treatment of Human Myeloid Leukemia. Mar Drugs (2016) 0.75
[4 cases of trisomy for the short arm of chromosome 9. Individualization of a new morbid entity]. Ann Genet (1970) 2.23
Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg (1969) 2.04
Isolation of beta-N-acetylhexosaminidase, beta-N-acetylglucosaminidase, and beta-N-acetylgalactosaminidase from calf brain. Biochemistry (1967) 1.69
Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet (1995) 1.59
Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem (1998) 1.52
[Trisomy for the distal part of the short arm of the number 3 chromosome in 3 siblings. First example of chromosomal insertion: INS(7;3)(q 31;p 21 p 26)]. Ann Genet (1972) 1.50
Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol (1998) 1.49
Avoiding palatopharyngeal trauma during videolaryngoscopy: do not forget the 'blind spots'. Acta Anaesthesiol Scand (2012) 1.47
Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J Biol Chem (2000) 1.45
Derivation and prospective testing of a two-step sevoflurane-O2-N2O low fresh gas flow sequence. Anaesth Intensive Care (2009) 1.38
[Mosaic 14 trisomy in a female child with multiple abnormalities]. Ann Genet (1975) 1.34
Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease. Crit Rev Biochem Mol Biol (1990) 1.32
Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J (1996) 1.31
Isolation of beta-galactosidase and beta-glucosidase from brain. Biochim Biophys Acta (1966) 1.31
Characterization of human acid sphingomyelinase purified from the media of overexpressing Chinese hamster ovary cells. Biochim Biophys Acta (1999) 1.30
Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radic Biol Med (2001) 1.28
Endoscopic ultrasonographic signs of portal hypertension in cirrhosis. Gastrointest Endosc (1996) 1.25
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia (2006) 1.24
Purification and separation of alpha- and beta-galactosidases from spinach leaves. Biochim Biophys Acta (1970) 1.24
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. Am J Med Genet (1985) 1.21
Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site. Proc Natl Acad Sci U S A (1986) 1.20
In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction. Cancer Res (1992) 1.17
Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine. Am J Hum Genet (1985) 1.17
Sphingomyelinases and Niemann-Pick disease. J Clin Chem Clin Biochem (1986) 1.16
Preparation and characterization of well defined D-erythro sphingomyelins. Chem Phys Lipids (1984) 1.16
Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase. Genomics (1998) 1.15
[Partial 7q trisomy due to t(7;12) (q22;q24) familial translocation]. Ann Genet (1972) 1.15
Enzymes of complex lipid metabolism. Annu Rev Biochem (1973) 1.14
Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol Pharmacol (2001) 1.14
Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J Biol Chem (1999) 1.13
Isolation of rat brain lecithinase-A, specific for the alpha'-position of lecithin. Biochem Biophys Res Commun (1966) 1.13
Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death Differ (2001) 1.12
Enzymatic hydrolysis of sphingolipids. II. Hydrolysis of sphingomyelin by an enzyme from rat brain. J Biol Chem (1966) 1.12
Antimalarial activities of dermaseptin S4 derivatives. Antimicrob Agents Chemother (2000) 1.10
A spectrophotometric method for determination of sphingomyelinase. Biochim Biophys Acta (1978) 1.10
Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells. Leukemia (2013) 1.10
A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem J (2001) 1.09
Continuing improvements in valvular bioprostheses. J Thorac Cardiovasc Surg (1982) 1.09
Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood (2001) 1.09
Involvement of FAN in TNF-induced apoptosis. J Clin Invest (2001) 1.08
Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes. J Biol Chem (1986) 1.07
Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology. FASEB J (2000) 1.07
Sphingomyelin suppresses the binding and utilization of low density lipoproteins by skin fibroblasts. J Biol Chem (1980) 1.06
Expression of mutated glucocerebrosidase alleles in human cells. Hum Mol Genet (1997) 1.06
L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J (1999) 1.06
Purification and properties of phospholipase A-1 from rat and calf brain. Biochim Biophys Acta (1968) 1.05
Enzymatic hydrolysis of sphingolipids. I. Hydrolysis and synthesis of ceramides by an enzyme from rat brain. J Biol Chem (1966) 1.04
Activity, pharmacological inhibition and biological regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in Trypanosoma brucei. Mol Biochem Parasitol (1995) 1.04
Enzymatic hydrolysis of sphingolipids. VII. Hydrolysis of gangliosides by a neuraminidase from calf brain. Biochim Biophys Acta (1968) 1.04
Host plasma low density lipoprotein particles as an essential source of lipids for the bloodstream forms of Trypanosoma brucei. J Biol Chem (1995) 1.04
Saposins (sap) A and C activate the degradation of galactosylceramide in living cells. FEBS Lett (1997) 1.03
Gaucher type I (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrate. Clin Chim Acta (1982) 1.02
CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway. J Biol Chem (1999) 1.01
Comparative study of the metabolic pools of sphingomyelin and phosphatidylcholine sensitive to tumor necrosis factor. Eur J Biochem (1996) 1.01
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. Cancer Res (1984) 1.01
Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res (1982) 1.01
Positive feedback control of neutral sphingomyelinase activity by ceramide. FASEB J (1998) 1.00
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). Br J Cancer (2004) 1.00
Osteopontin is associated with bioprosthetic heart valve calcification in humans. C R Acad Sci III (1997) 1.00
Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene. J Med Genet (1996) 1.00
[Partial trisomy of chromosome 21 by maternal translocation t(15;21) (q26.2; q21)]. Ann Genet (1976) 1.00
Synthesis of a fluorescent derivative of glucosyl ceramide for the sensitive determination of glucocerebrosidase activity. Anal Biochem (1984) 0.99
Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets. Int J Cancer (2001) 0.99
Antineoplastic activity of poly(L-lysine) with some ascites tumor cells. Proc Natl Acad Sci U S A (1979) 0.99
Prejunctional and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric arterial bed of the rat. J Cardiovasc Pharmacol (1987) 0.98
Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. II. Uptake and cytotoxicity of ultraviolet-treated LDL on lymphoid cell lines. Biochim Biophys Acta (1990) 0.98
Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway. J Biol Chem (2000) 0.98
Isolation of lysophospholipase, free of phospholipase activity, from rat brain. Biochim Biophys Acta (1968) 0.97
The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J Biol Chem (1996) 0.97
[Effect of the ionic medium on controlled heat denaturation of human chromosomes]. Ann Genet (1972) 0.96
Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue. FEBS Lett (1998) 0.96
Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes. Cardiovasc Res (1999) 0.96
Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog Lipid Res (2000) 0.96
Bronchoalveolar lavage in liquid paraffin pneumonitis. Chest (1990) 0.95
Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation. Cell Death Dis (2013) 0.95
A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity. Anal Biochem (1999) 0.95
Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies. Clin Chim Acta (1997) 0.95
Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins. J Photochem Photobiol B (1990) 0.95
Esmolol for control of increases in heart rate and blood pressure during tracheal intubation after thiopentone and succinylcholine. Can Anaesth Soc J (1986) 0.94
Retrovirus-mediated correction of the metabolic defect in cultured Farber disease cells. Hum Gene Ther (1999) 0.94
Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase-deficient mice. Transplantation (1998) 0.94
Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy. Clin Genet (2013) 0.94
[Increase of the LDH-B activity in a boy with 12p trisomy by malsegregation of a maternal translocation t(12;14) (q12;p11)]. Ann Genet (1975) 0.94
Three unrelated sphingomyelin analogs spontaneously cluster into plasma membrane micrometric domains. Biochim Biophys Acta (2010) 0.93
Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease. Clin Chim Acta (1988) 0.93
Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites. Arch Biochem Biophys (1984) 0.92
Lysosomal sphingomyelinase is not solicited for apoptosis signaling. FASEB J (2000) 0.92
The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. Mol Pharmacol (2001) 0.92
Preselective gene therapy for Fabry disease. Proc Natl Acad Sci U S A (2001) 0.92